Search

Your search keyword '"Di Francesco A"' showing total 537 results
Start Over Author "Di Francesco A" Publisher elsevier b.v.
537 results on '"Di Francesco A"'

1. A MEPS-UHPLC-MS/MS analytical platform to detect isoprostanoids and specialized pro-resolving mediators in the urinary extracellular vesicles of mountain ultramarathon runners

Author

Biagini, Denise, Mrakic-Sposta, Simona, Bondi, Danilo, Ghimenti, Silvia, Lenzi, Alessio, Vivaldi, Federico, Santangelo, Carmen, Verratti, Vittore, Pietrangelo, Tiziana, Vezzoli, Alessandra, Giardini, Guido, Oger, Camille, Galano, Jean-Marie, Balas, Laurence, Durand, Thierry, D'Angelo, Gennaro, Lomonaco, Tommaso, and Di Francesco, Fabio

Published
2024
Full Text
View/download PDF

11. A casein-based biodegradable and sustainable capacitive sensor

Author

De Gregorio, Elena, Miliani, Filippo Manfredi, Vivaldi, Federico Maria, Calisi, Nicola, Poma, Noemi, Tavanti, Arianna, Duce, Celia, Nardella, Federica, Legnaioli, Stefano, Carota, Angela Gilda, Strambini, Lucanos, Biagini, Denise, Lomonaco, Tommaso, Di Francesco, Fabio, and Salvo, Pietro

Published
2024
Full Text
View/download PDF

12. Improving outcomes of in situ split liver transplantation in Italy over the last 25 years

Author

Lauterio, Andrea, Cillo, Umberto, Spada, Marco, Trapani, Silvia, De Carlis, Riccardo, Bottino, Giuliano, Bernasconi, Davide, Scalamogna, Chiara, Pinelli, Domenico, Cintorino, Davide, D’Amico, Francesco Enrico, Spagnoletti, Gionata, Miggino, Marco, Romagnoli, Renato, Centonze, Leonardo, Caccamo, Lucio, Baccarani, Umberto, Carraro, Amedeo, Cescon, Matteo, Vivarelli, Marco, Mazaferro, Vincenzo, Ettorre, Giuseppe Maria, Rossi, Massimo, Vennarecci, Giovanni, De Simone, Paolo, Angelico, Roberta, Agnes, Salvatore, Di Benedetto, Fabrizio, Lupo, Luigi Giovanni, Zamboni, Fausto, Zefelippo, Arianna, Patrono, Damiano, Diviacco, Pietro, Laureiro, Zoe Larghi, Gringeri, Enrico, Di Francesco, Fabrizio, Lucianetti, Alessandro, Valsecchi, Maria Grazia, Gruttadauria, Salvatore, De Feo, Tullia, Cardillo, Massimo, De Carlis, Luciano, Colledan, Michele, and Andorno, Enzo

Published
2023
Full Text
View/download PDF

24. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients

Author

Balestrieri, Emanuela, Minutolo, Antonella, Petrone, Vita, Fanelli, Marialaura, Iannetta, Marco, Malagnino, Vincenzo, Zordan, Marta, Vitale, Pietro, Charvet, Benjamin, Horvat, Branka, Bernardini, Sergio, Garaci, Enrico, di Francesco, Paolo, Sinibaldi Vallebona, Paola, Sarmati, Loredana, Grelli, Sandro, Andreoni, Massimo, Perron, Hervé, and Matteucci, Claudia

Published
2021
Full Text
View/download PDF

38. Improving outcomes of in situ split liver transplantation in Italy over the last 25 years

Author

Lauterio, A, Cillo, U, Spada, M, Trapani, S, De Carlis, R, Bottino, G, Bernasconi, D, Scalamogna, C, Pinelli, D, Cintorino, D, D'Amico, F, Spagnoletti, G, Miggino, M, Romagnoli, R, Centonze, L, Caccamo, L, Baccarani, U, Carraro, A, Cescon, M, Vivarelli, M, Mazaferro, V, Ettorre, G, Rossi, M, Vennarecci, G, De Simone, P, Angelico, R, Agnes, S, Di Benedetto, F, Lupo, L, Zamboni, F, Zefelippo, A, Patrono, D, Diviacco, P, Laureiro, Z, Gringeri, E, Di Francesco, F, Lucianetti, A, Valsecchi, M, Gruttadauria, S, De Feo, T, Cardillo, M, De Carlis, L, Colledan, M, Andorno, E, Lauterio A., Cillo U., Spada M., Trapani S., De Carlis R., Bottino G., Bernasconi D., Scalamogna C., Pinelli D., Cintorino D., D'Amico F. E., Spagnoletti G., Miggino M., Romagnoli R., Centonze L., Caccamo L., Baccarani U., Carraro A., Cescon M., Vivarelli M., Mazaferro V., Ettorre G. M., Rossi M., Vennarecci G., De Simone P., Angelico R., Agnes S., Di Benedetto F., Lupo L. G., Zamboni F., Zefelippo A., Patrono D., Diviacco P., Laureiro Z. L., Gringeri E., Di Francesco F., Lucianetti A., Valsecchi M. G., Gruttadauria S., De Feo T., Cardillo M., De Carlis L., Colledan M., Andorno E., Lauterio, A, Cillo, U, Spada, M, Trapani, S, De Carlis, R, Bottino, G, Bernasconi, D, Scalamogna, C, Pinelli, D, Cintorino, D, D'Amico, F, Spagnoletti, G, Miggino, M, Romagnoli, R, Centonze, L, Caccamo, L, Baccarani, U, Carraro, A, Cescon, M, Vivarelli, M, Mazaferro, V, Ettorre, G, Rossi, M, Vennarecci, G, De Simone, P, Angelico, R, Agnes, S, Di Benedetto, F, Lupo, L, Zamboni, F, Zefelippo, A, Patrono, D, Diviacco, P, Laureiro, Z, Gringeri, E, Di Francesco, F, Lucianetti, A, Valsecchi, M, Gruttadauria, S, De Feo, T, Cardillo, M, De Carlis, L, Colledan, M, Andorno, E, Lauterio A., Cillo U., Spada M., Trapani S., De Carlis R., Bottino G., Bernasconi D., Scalamogna C., Pinelli D., Cintorino D., D'Amico F. E., Spagnoletti G., Miggino M., Romagnoli R., Centonze L., Caccamo L., Baccarani U., Carraro A., Cescon M., Vivarelli M., Mazaferro V., Ettorre G. M., Rossi M., Vennarecci G., De Simone P., Angelico R., Agnes S., Di Benedetto F., Lupo L. G., Zamboni F., Zefelippo A., Patrono D., Diviacco P., Laureiro Z. L., Gringeri E., Di Francesco F., Lucianetti A., Valsecchi M. G., Gruttadauria S., De Feo T., Cardillo M., De Carlis L., Colledan M., and Andorno E.

Abstract

Background & Aims: Split liver transplant(ation) (SLT) is still considered a challenging procedure that is by no means widely accepted. We aimed to present data on 25-year trends in SLT in Italy, and to investigate if, and to what extent, outcomes have improved nationwide during this time. Methods: The study included all consecutive SLTs performed from May 1993 to December 2019, divided into three consecutive periods: 1993–2005, 2006–2014, and 2015–2019, which match changes in national allocation policies. Primary outcomes were patient and graft survival, and the relative impact of each study period. Results: SLT accounted for 8.9% of all liver transplants performed in Italy. A total of 1,715 in situ split liver grafts were included in the analysis: 868 left lateral segments (LLSs) and 847 extended right grafts (ERGs). A significant improvement in patient and graft survival (p <0.001) was observed with ERGs over the three periods. Predictors of graft survival were cold ischaemia time (CIT) <6 h (p = 0.009), UNOS status 2b (p <0.001), UNOS status 3 (p = 0.009), and transplant centre volumes: 25–50 cases vs. <25 cases (p = 0.003). Patient survival was significantly higher with LLS grafts in period 2 vs. period 1 (p = 0.008). No significant improvement in graft survival was seen over the three periods, where predictors of graft survival were CIT <6 h (p = 0.007), CIT <6 h vs. ≥10 h (p = 0.019), UNOS status 2b (p = 0.038), and UNOS status 3 (p = 0.009). Retransplantation was a risk factor in split liver graft recipients, with significantly worse graft and patient survival for both types of graft (p <0.001). Conclusions: Our analysis showed Italian SLT outcomes to have improved over the last 25 years. These results could help to dispel reservations regarding the use of this procedure. Impact and implications: Split liver transplant(ation) (SLT) is still considered a challenging procedure and is by no means widely accepted. This study included all

Published
2023

46. Yeasts volatile organic compounds (VOCs) as potential growth enhancers and molds biocontrol agents of mushrooms mycelia.

Author

Di Francesco, Alessandra, Moret, Erica, Cignola, Rudy, Garagozzo, Luca, Torelli, Emanuela, and Di Foggia, Michele

Subjects
*VOLATILE organic compounds, *BIOLOGICAL pest control agents, *MOLDS (Fungi), *YEAST, *MUSHROOMS, *AUREOBASIDIUM pullulans, *TRICHODERMA
Abstract

Volatile organic compounds (VOCs) produced by yeasts can positively affect crops, acting as antifungals or biostimulants. In this study, Aureobasidium pullulans and Metschnikowia pulcherrima were evaluated as potential antagonists of Trichoderma spp., common fungal pathogen in mushroom cultivation. To assess the biocontrol ability and biostimulant properties of the selected yeast species, in vitro co-culture and VOCs exposure assays were conducted. In both assays, VOCs produced by Aureobasidium spp. showed the stronger antifungal activity with a growth inhibition up to 30 %. This result was further confirmed by the higher volatilome alcohol content revealed by solid phase microextraction-gas chromatography mass spectrometry (SPME/GC–MS). Overall, Aureobasidium strains can be potentially used as biocontrol agent in Pleorotus ostreatus and Cyclocybe cylindracea mycelial growth, without affecting their development as demonstrated by VOCs exposure assay and Fourier-transform infrared spectroscopy (FT-IR). Conversely, M. pulcherrima was characterized by a lower or absent antifungal properties and by a volatilome composition rich in isobutyl acetate, an ester often recognized as plant growth promoter. As confirmed by FT-IR, Lentinula mycelia exposed to M. pulcherrima VOCs showed a higher content of proteins and lipids, suggesting an improvement of some biochemical properties. Our study emphasizes that VOCs produced by specific yeast strains are potentially powerful alternative to synthetic fungicide in the vegetative growth of mushroom-forming fungi and also able to modify their biochemical composition. • Yeasts VOCs are characterized by different antifungal and biostimulant properties. • Aureobasidium spp. VOC have the stronger antifungal activity against Trichoderma spp. • M. pulcherrima VOCs improve mushrooms growth and nutritional characteristics. • FT-IR spectra suggested M. pulcherrima VOCs as biostimulant of Lentinula edodes. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results